Hjem › Leverkreft (hepatocellulært karcinom) › District of Columbia › Washington
Kliniske studier for Leverkreft (hepatocellulært karcinom) i Washington, DC
10 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Evaluating Novel Therapies in ctDNA Positive GI Cancers
RekruttererFase 3
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Children's National Medical Center, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekruttererFase 2
- USA11-0, Bethesda · 7 mi unna
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi unna
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi unna
Leverkreft (hepatocellulært karcinom)-studier i andre byer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.